Strategic Communications and Marketing News Bureau

Modified bone drug kills malaria parasite in mice

CHAMPAIGN, lll. – A chemically altered osteoporosis drug may be useful in fighting malaria, researchers report in a new study. Unlike similar compounds tested against many other parasitic protozoa, the drug readily crosses into the red blood cells of malaria-infected mice and kills the malaria parasite. The drug works at very low concentrations with no observed toxicity to the mouse.

The study appears in the Proceedings of the National Academy of Sciences.

The researchers found the drug by screening a library of about 1,000 compounds used in previous efforts to target an important biochemical pathway (called isoprenoid biosynthesis) in cancer and in disease-causing organisms. The new drug lead, BPH-703, inhibits a key enzyme in isoprenoid biosynthesis that enables the malaria parasite to sustain itself and defend itself from the host immune system. The drug has little effect on the same chemical pathway in human or mouse cells, said University of Illinois chemistry professor Eric Oldfield, who led the study.

The lead compounds are chemically modified forms of the osteoporosis drugs Actonel (Risedronate) and Zometa (Zoledronate), Oldfield said. Risedronate and Zoledronate potently block isoprenoid biosynthesis, but are unable to get across the membrane of red blood cells to get to the parasite. The modified forms include a long lipid tail that helps them pass through the lipid-rich membrane of red blood cells, and also enhances the drug’s ability to bind to the target enzyme, geranylgeranyl diphosphate synthase (GGPPS), he said.

“We found that compounds that were really active had a very long hydrocarbon chain,” Oldfield said. “These compounds can cross the cell membrane and work at very low concentrations.”

The World Health Organization estimates that malaria killed 708,000 to 1.003 million people in 2008, most of them in Sub-Saharan Africa and Asia. The malaria parasite has evolved resistance to nearly every drug used so far to combat it, and while some of these drugs still work – especially when used in combination – drug-resistant malaria strains are always emerging.

“It’s important to find new drug targets because malaria drugs last only a few years, maybe 10 years, before you start to get resistance,” Oldfield said. “The parasites mutate and then you lose your malaria drug.”

“We are the first to show that the enzyme GGPPS is a valid target for malaria,” said study co-author Yonghui Zhang, a research scientist in Oldfield’s lab and inventor of the lead compound, BPH-703. “Our work gives a new direction to find new antimalarial drugs.”

Editor’s note: To contact Eric Oldfield, call: 217-333-3374; email eoldfiel@illinois.edu.

The paper, “Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium GGPPS and exhibit potent anti-malarial activity,” is available from the U. of I. News Bureau.

Read Next

Life sciences Photo of Michael Ward standing in tall grass on a riverbank.

How are migrating wild birds affected by H5N1 infection in the U.S.?

Each spring, roughly 3.5 billion wild birds migrate from their warm winter havens to their breeding grounds across North America, eating insects, distributing plant seeds and providing a variety of other ecosystem services to stopping sites along the way. Some also carry diseases like avian influenza, a worry for agricultural, environmental and public health authorities. […]

Announcements Marcelo Garcia, professor of civil and environmental engineering at The Grainger College of Engineering.

Illinois faculty member elected to National Academy of Engineering

Champaign, Ill. — Marcelo Garcia, a professor of civil and environmental engineering in The Grainger College of Engineering, has been elected to the National Academy of Engineering.

Social sciences Male and female student embracing on the quad with flowering redbud tree and the ACES library in the background. Photo by Michelle Hassel

Dating is not broken, but the trajectories of relationships have changed

CHAMPAIGN, Ill. — According to some popular culture writers and online posts by discouraged singles lamenting their inability to find romantic partners, dating is “broken,” fractured by the social isolation created by technology, pandemic lockdowns and potential partners’ unrealistic expectations. Yet two studies of college students conducted a decade apart found that their ideas about […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010